Natalizumab-associated progressive multifocal leucoencephalopathy: a report of 3 cases, and implications for successful treatment

被引:0
|
作者
Kalamatas, T. [1 ]
Travasarou, M. [1 ]
Giannouli, E. [1 ]
Marousi, S. [1 ]
Samara, C. [1 ]
Karageorgiou, K. [1 ]
机构
[1] G Gennimatas Athens Gen Hosp, Athens, Greece
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P999
引用
收藏
页码:S454 / S454
页数:1
相关论文
共 50 条
  • [31] Determinants of clinical outcomes for patients with Natalizumab-associated progressive multifocal leukoencephalopathy
    Kappos, L.
    Mcguigan, C.
    Derfuss, T.
    Giovannoni, G.
    Oh, J.
    Ren, Z.
    McCarthy, K.
    Chang, I.
    Campbell, N.
    Ho, P. -R.
    Mason, L.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 19 - 20
  • [32] Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy
    Decard, Bernhard F.
    Haghikia, Aiden
    Toennes, Christina
    Thoene, Jan
    Lukas, Carsten
    Chan, Andrew
    Gold, Ralf
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (02) : 249 - 251
  • [33] Re-evaluating the incidence of natalizumab-associated progressive multifocal leukoencephalopathy
    Borchardt, Julian
    Berger, Joseph R.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 8 : 145 - 150
  • [34] Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy
    Tuan Dong-Si
    Gheuens, Sarah
    Gangadharan, Amy
    Wenten, Made
    Philip, Jeffrey
    McIninch, James
    Datta, Shoibal
    Richert, Nancy
    Bozic, Carmen
    Bloomgren, Gary
    Richman, Sandra
    Weber, Thomas
    Clifford, David B.
    JOURNAL OF NEUROVIROLOGY, 2015, 21 (06) : 637 - 644
  • [35] Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy
    Hoepner, Robert
    Kolb, Eva M.
    Dahlhaus, Stefanie
    Hellwig, Kerstin
    Adams, Ortwin
    Kleiter, Ingo
    Salmen, Anke
    Schneider, Ruth
    Lukas, Carsten
    Chan, Andrew
    Berger, Joseph R.
    Gold, Ralf
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (06) : 830 - 835
  • [36] A Case of Natalizumab-associated Progressive Multifocal Leukoencephalopathy—Role for Advanced MRI?
    M. Berghoff
    B. Dassinger
    J. Iwinska-Zelder
    M. Giraldo
    S. Bilgin
    M. Kaps
    E. R. Gizewski
    Clinical Neuroradiology, 2014, 24 : 173 - 176
  • [37] Quantitative electroencephalography supports diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy
    G. Classen
    C. Classen
    C. Bernasconi
    C. Brandt
    R. Gold
    A. Chan
    R. Hoepner
    Journal of NeuroVirology, 2019, 25 : 133 - 136
  • [38] Atypical MRI features at early onset natalizumab-associated progressive multifocal leukoencephalopathy: A case report
    Piola, Mirko
    Di Palma, Franco
    Mascoli, Nerina
    Binda, Sandro
    Arnaboldi, Marco
    Rezzonico, Monica
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 340 (1-2) : 213 - 214
  • [39] Quantitative electroencephalography supports diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy
    Classen, G.
    Classen, C.
    Bernasconi, C.
    Brandt, C.
    Gold, R.
    Chan, A.
    Hoepner, R.
    JOURNAL OF NEUROVIROLOGY, 2019, 25 (01) : 133 - 136
  • [40] Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy
    Yousry, Tarek A.
    Pelletier, Daniel
    Cadavid, Diego
    Gass, Achim
    Richert, Nancy D.
    Radue, Ernst-Wilhelm
    Filippi, Massimo
    ANNALS OF NEUROLOGY, 2012, 72 (05) : 779 - 787